Dolby Laboratories, Inc.

NYSE:DLB 株式レポート

時価総額：US$5.4b

Dolby Laboratories 過去の業績

過去 基準チェック /16

Dolby Laboratoriesの収益は年間平均-1.4%の割合で減少していますが、 Software業界の収益は年間 増加しています。収益は年間21.2% 1.6%割合で 増加しています。 Dolby Laboratoriesの自己資本利益率は9.3%であり、純利益率は17.9%です。

主要情報

-1.45%

収益成長率

0.10%

EPS成長率

Software 業界の成長17.33%
収益成長率1.64%
株主資本利益率9.34%
ネット・マージン17.85%
前回の決算情報27 Mar 2026

最近の業績更新

Recent updates

Dolby: I Don't Mind Waiting In 2026

May 03

DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains

Analysts have adjusted their price target for Dolby Laboratories from $90.50 to $81.00, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Dolby Atmos is being introduced in the new BMW 7 Series through BMW's Bowers & Wilkins Diamond Surround Sound System, which includes up to 36 speakers and 1,965 watts and is aimed at creating a three-dimensional in-car listening experience (Key Developments).

DLB: Expanding Premium Cinema Footprint And Ongoing Buybacks Will Support Upside

Analysts are keeping their price target for Dolby Laboratories steady at $90.00. They point to only minor adjustments in the discount rate, revenue growth assumptions and profit margin outlook, along with a slightly lower future P/E multiple in their refreshed models.

DLB: Future Streaming Expansion And Ongoing Buybacks Will Support Upside Outlook

Analysts have maintained their $90.00 price target for Dolby Laboratories, reflecting updated assumptions that include a slightly lower discount rate, modestly higher revenue growth and profit margin, and a slightly reduced future P/E multiple. What's in the News From September 27, 2025 to December 26, 2025, Dolby repurchased 1,044,838 shares for US$70 million, representing 1.09% of shares, completing a total of 53,316,704 shares repurchased for US$3,094.61 million under the buyback announced on November 3, 2009 (company filing).

DLB: Future Streaming Technology Adoption Will Support A More Optimistic Outlook

Analysts have revised their price target for Dolby Laboratories from $114.00 to $90.00. They cite updated assumptions around revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change.

DLB: Media Partnerships And Buybacks Will Support Measured Future Returns

Analysts are keeping their price target for Dolby Laboratories steady at $68.00. This points to largely unchanged expectations around fair value, discount rate, revenue growth, profit margin and future P/E assumptions.

DLB: Broad Media Partnerships And Buybacks Will Support Steady Returns

Analysts maintained their Dolby Laboratories fair value estimate at $68.00, with only minor adjustments to assumptions around discount rate, revenue growth, profit margin, and future P/E informing the updated price target rationale. What's in the News Dolby updated earnings guidance for the second quarter of fiscal 2026, with total revenue estimated at US$375 million to US$405 million and GAAP diluted EPS expected at US$0.94 to US$1.09.

DLB: Ongoing Technology Adoption Will Support Returns Despite Choppy Macro Conditions

Analysts have trimmed their price targets on Dolby Laboratories to a range of about $85 to $95. This reflects a more cautious stance on the stock while still pointing to solid recent results and ongoing technology adoption, even as the macro backdrop pressures some revenue streams.

Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 02
Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

DLB: Technology Adoption And Solid Execution Will Support Future Share Gains

Narrative Update on Dolby Laboratories The analyst price target for Dolby Laboratories has shifted down to a range of about $85 to $95 per share. Analysts point to a solid fiscal Q4, guidance in line with expectations, and continued technology adoption despite macro headwinds as key reasons for the updated view.

DLB: Steady Outlook Will Balance Macro Pressures And Expanding Technology Adoption

Analysts have trimmed their price targets for Dolby Laboratories, with recent moves from $100 to $95 and from $95 to $85, as they weigh steady guidance and progress in technology adoption against ongoing macro headwinds affecting foundational revenues. Analyst Commentary Recent research updates show that bearish analysts are trimming their expectations for Dolby Laboratories even as they acknowledge stable guidance and a solid fiscal fourth quarter.

Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 42% Undervaluation?

Jan 05
Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 42% Undervaluation?

DLB: Cautious Outlook Will Weigh On Shares Despite Expanding Technology Adoption

Analysts have trimmed their fair value estimate for Dolby Laboratories from $74.00 to $68.00, citing slightly higher discount-rate assumptions despite improving revenue growth and profit margin expectations. They continue to support maintaining a constructive long term outlook.

DLB: Durable Business Model Will Support Future Gains Despite Macro Headwinds

Analysts have trimmed their price targets for Dolby Laboratories by roughly 10 dollars to reflect ongoing macro headwinds to foundational revenues. At the same time, they highlight solid quarterly execution and continued adoption of the company’s technologies as support for maintaining positive ratings.

DLB: Durable Business Model Will Support Long-Term Stability Amid Macroeconomic Headwinds

Analysts have reduced their fair value price target for Dolby Laboratories from $95.75 to $90.50, citing continued macroeconomic headwinds but also recognizing progress in revenue growth and profitability. Analyst Commentary Recent Street research highlights a mix of optimism about Dolby Laboratories' underlying business strengths and caution regarding ongoing macroeconomic challenges.

The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

Nov 11
The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

Investor Optimism Abounds Dolby Laboratories, Inc. (NYSE:DLB) But Growth Is Lacking

Sep 27
Investor Optimism Abounds Dolby Laboratories, Inc. (NYSE:DLB) But Growth Is Lacking

Expanding Auto And Device Ecosystems Will Define Immersive Entertainment

Despite Dolby Laboratories' durable business model, growing licensing revenues, and long-term growth potential from strategic partnerships, analysts have trimmed the price target from $103.00 to $95.75 due to uninspiring device markets, macroeconomic uncertainty, and a lack of near-term catalysts. Analyst Commentary Growing licensing revenues and increased adoption across key markets support positive sentiment.

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Jul 28
What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 33% Below Their Intrinsic Value Estimate

May 27
Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 33% Below Their Intrinsic Value Estimate

Should You Be Adding Dolby Laboratories (NYSE:DLB) To Your Watchlist Today?

May 06
Should You Be Adding Dolby Laboratories (NYSE:DLB) To Your Watchlist Today?

Dolby Laboratories Remains Fully Valued On Slow Growth

Feb 07

Dolby Laboratories: Picture Improved, But Still A Bit Too Expensive

Nov 22

収支内訳

Dolby Laboratories の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

NYSE:DLB 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
27 Mar 261,365244657266
26 Dec 251,339241645264
26 Sep 251,349255647262
27 Jun 251,347264640263
28 Mar 251,320257628262
27 Dec 241,315263625263
27 Sep 241,274262605264
28 Jun 241,259212605265
29 Mar 241,269190614269
29 Dec 231,280188615274
29 Sep 231,300201613272
30 Jun 231,287219603263
31 Mar 231,279242591257
30 Dec 221,237183617257
30 Sep 221,254184634261
01 Jul 221,261201639261
01 Apr 221,258216632260
31 Dec 211,243255587259
24 Sep 211,281310557254
25 Jun 211,267293541253
26 Mar 211,228306526251
25 Dec 201,260318538245
25 Sep 201,162231556239
26 Jun 201,189248554238
27 Mar 201,245221570238
27 Dec 191,231206560237
27 Sep 191,242255549238
28 Jun 191,183238550238
29 Mar 191,096201541238
28 Dec 181,057193525239
28 Sep 181,05542507237
29 Jun 181,05637490234
30 Mar 181,147110480233
29 Dec 171,11595474232
29 Sep 171,080206468233
30 Jun 171,072204464235
31 Mar 171,044192463230
30 Dec 161,051208458224
30 Sep 161,026186464220
01 Jul 161,025208470211
01 Apr 16980180470202
01 Jan 16977171467206
25 Sep 15971181461201
26 Jun 15965181449198

質の高い収益: DLBは 高品質の収益 を持っています。

利益率の向上: DLBの現在の純利益率 (17.9%)は、昨年(19.4%)よりも低くなっています。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: DLBの収益は過去 5 年間で年間1.4%減少しました。

成長の加速: DLBは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。

収益対業界: DLBは過去 1 年間で収益成長率がマイナス ( -5.1% ) となったため、 Software業界平均 ( 14.3% ) と比較することが困難です。

株主資本利益率

高いROE: DLBの 自己資本利益率 ( 9.3% ) は 低い とみなされます。

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/05/04 23:22
終値2026/05/04 00:00
収益2026/03/27
年間収益2025/09/26

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Dolby Laboratories, Inc. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13

アナリスト機関
Vikram KesavabhotlaBaird
Patrick ShollBarrington Research Associates, Inc.
Eric WoldB. Riley Securities, Inc.